chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Ten days after receiving my second booster, as recommended by the CDC and doctors, I became very light headed and  out of breath, needing to sit or lie down. Then throughout the morning, I was short of breath and light headed. I went to my doctor's office, who recommended I go to the Emergency Department of our local hospital. After CT imaging and bloodwork, it was determined I had a large Pulmonary embolism in my right lung and a smaller one in my left lung. After imaging of my legs, DVTs were also discovered there. Exactly 10 days after my 3rd dose (first booster) I also was diagnosed with a DVT (blood clot). I had never had a blood clot prior. Both of these occurances happened exactly 10 days after each vaccination.
1. Right-sided chest pain and decreased aeration on Right lung (3 lobes) The pt was imaged to rule out spontaneous pneumothorax - MBI:XRY  Chest, PA and Lateral (STANDARD) IMPRESSION: Large right pneumothorax with pronounced collapse of the right lung
Patient was accidentally vaccinated. Patient was previously unvaccinated and has never received any Covid vaccine. On the date of clinic patient receive the Pfizer Bivalent . Responsible party which is her son and the doctor was made aware. Patient displays no signs or symptoms of adverse reaction. Alert charting initiated. Monitoring continues. No issues right now.
Blotch dots on rash; Rash around injection site/Rash is smooth; Taste of coffee and all drinks and food "odd","funny taste", "yucky; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Taste of coffee and all drinks and food "odd","funny taste", "yucky), RASH MACULAR (Blotch dots on rash) and VACCINATION SITE RASH (Rash around injection site/Rash is smooth) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced TASTE DISORDER (Taste of coffee and all drinks and food "odd","funny taste", "yucky). On 30-Apr-2021, the patient experienced RASH MACULAR (Blotch dots on rash) and VACCINATION SITE RASH (Rash around injection site/Rash is smooth). At the time of the report, TASTE DISORDER (Taste of coffee and all drinks and food "odd","funny taste", "yucky), RASH MACULAR (Blotch dots on rash) and VACCINATION SITE RASH (Rash around injection site/Rash is smooth) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication provided   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received on 30-APR-2021. New events added
Sore arm, hives at injection sight, shortness of breath after walking long distances, extremely high blood pressure, chest pains and tightening in chest.  Diagnosed with SVT and high blood pressure.
Immediately after the Gardasil injection (the other two were done a couple minutes earlier) pain, very light-headed and very nauseous. Told nurses and sat down for 30-40 minutes until the symptoms had mostly passed. Nurses checked on twice, was allowed to leave after last nurse check.
Influenza A; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA (Influenza A) in a 17-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AR9237B and AR9237B) for COVID-19 prophylaxis.     Patient had no known allergies.  Patient had no chronic or long-standing health condition. The patient never been diagnosed with/ tested positive for COVID-19.  Concomitant products included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DAPTACEL) and HEPATITIS A VACCINE INACT (VAQTA) for an unknown indication.   On 06-Sep-2022 at 3:22 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 04-Oct-2022 at 3:23 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 06-Jan-2023, the patient experienced INFLUENZA (Influenza A). At the time of the report, INFLUENZA (Influenza A) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment drug was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-713298 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-713298:Bivalent dose case
This 78 year old male received the Covid shot on 2/26/2021 and died the next day on 2/27/21.  Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
Cellulitis at the injection site in the left deltoid, extending down to the elbow.  Patient started on antibiotics today.
On 11/14/08 a fine rash appeared on patient's breasts, back, and bilateral calves. Rash is itchy, no drainage or fever noted. Rash remains, but with improvement using OTC antihistamine and topical steroid cream.
Severe Body pain, temp, nausea and vomiting, Severe Headache - described as "48 hrs of the worst pain I have ever endured."
Left face at scalp broken out, started 1 week ago and started spreading. 3 or 4 days ago starting itching. Seen at clinic 1/2/04 and diagnosed with shingles and treated with acyclovir.
hearing loss in his right ear; This is a spontaneous report from a contactable consumer (patient).   A 33-year-old male patient received bnt162b2 (BNT162B2), at the age of 33-years at vaccination, dose 2 via an unspecified route of administration, administered in Arm Left on 24Mar2021 15:15 (Batch/Lot Number: EL3248) as SINGLE DOSE, dose 1 via an unspecified route of administration on 02Mar2021 13:00 (Batch/Lot Number: EN6203) as SINGLE DOSE for covid-19 immunisation.  Prior to vaccination, the patient was not diagnosed with COVID 19. The patient's medical history and concomitant medications were not reported.  On 24Mar2021 22:00, patient experienced hearing loss in his right ear with outcome of not recovered.  Since the vaccination, the patient has not been tested for COVID 19.   Information on Lot/Batch number was available. Additional information has been requested.
Myalgia 1/2/2021 REPORTS HANDS/LEGS MOTTLED AND COLD, EXTREME FATIGUE THAT LASTED UNTIL ABOUT NOON 1/4/2021; STILL WITH CHILLS, FATIGUE Narrative:
Bad reaction; Red body; Dizziness; Couldn't stand; Difficulty breathing; Spotty rash elsewhere; Pain; joint pain; fatigue; Muscle aches; Fever of 100.7; A bad rash down arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Bad reaction), ERYTHEMA (Red body), DIZZINESS (Dizziness), DYSSTASIA (Couldn't stand) and DYSPNOEA (Difficulty breathing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had a COVID  worse.) in October 2020 and Pneumonia (Because of Covid-19.) in October 2020. Concurrent medical conditions included Colitis and Hypothyroidism.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced VACCINATION COMPLICATION (Bad reaction), ERYTHEMA (Red body), DIZZINESS (Dizziness), DYSSTASIA (Couldn't stand), DYSPNOEA (Difficulty breathing), RASH MACULAR (Spotty rash elsewhere), PAIN (Pain), ARTHRALGIA (joint pain), FATIGUE (fatigue), MYALGIA (Muscle aches), PYREXIA (Fever of 100.7) and RASH (A bad rash down arm). At the time of the report, VACCINATION COMPLICATION (Bad reaction), ERYTHEMA (Red body), DIZZINESS (Dizziness), DYSSTASIA (Couldn't stand), DYSPNOEA (Difficulty breathing), RASH MACULAR (Spotty rash elsewhere), PAIN (Pain), ARTHRALGIA (joint pain), FATIGUE (fatigue), MYALGIA (Muscle aches), PYREXIA (Fever of 100.7) and RASH (A bad rash down arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, Antibody test: positive (Positive) Positive. In November 2020, Pyrexia: 100.7 (High) 100.7F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       In addition to the others historical condition patient has several other problems. No concomitant medication was reported.  Reported said that most of the symptoms occurred at times from 1-May-2021 to about 7-May-2021. No treatment was reported.
Mouth with numbness inside and left arm had strange feeling also two fingers on left arm that lasted for 2 hours.
Within one day patient felt tingly, weak, and collapsed. Progressed into patients face and tongue currently.
Second shot/injection took place at noon three weeks ago. At midnight following the second shot I woke up with very intense joint pain throughout my body paired with a fire-y more ?nerve-type? pain.    The symptoms described above subsided after about 6 hours then there was a lingering headache for the remainder of the day and my knees remained very sore. Both knees have had multiple surgeries and have signs of early arthritis due to sports injuries. It has been nearly three weeks and my knee joints continue to ache and be more stiff than prior to the side-effect event following the second shot.   I haven?t yet contacted my doctor hoping it will subside on its own, but wanted to report this in case others experience something similar.
I was injected in the right arm with Moderna COVID-19 Vaccine EUA 0n 1/8/2021, 9:57 am at Clinic.  I waited 15 minutes before I left the facility and okay.  Did move my right arm so not to be sore.  Worked regular shift: 4 pm to 10 pm and started to feel cramping.  at 11:25pm, began to chill and body aches,  took 2 Tylenol tablets for pain.  did glucose injections : humalog: 38 units and Toujeo 54 units ( glucose was 257).  Regular medications: Lisinopril 40 mg, Atorvastatin 40 mg, metoprolol 25 mg, Spironolactone 25 mg and Meloxicam 7.5 mg.  Went to bed at 11:45 pm, with 3 extra blankets and winter pajamas.  Woke at 1:30 am with hot flash (thinking fever) Could not find Thermometer, still had aches and pains, nausea,  headache and fatigue.  Contacted staff on call and replacement for Saturday shift.  Went to 24 hour pharmacy and purchased a digital thermometer.  I did have elevated temperature.  I usually rate normal temperature of 96 to 97.7 and temperature was at 99 when taken at 3 am in the morning.  Temperature remained below 99 when taken on Saturday.  Rested and ate properly, maintained good glucose readings.  Returned to work on Sunday morning.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 28-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 14-Oct-2020 and the estimated date of delivery was 21-Jul-2021. On 29-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifteenth week of the pregnancy.  At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not reported . Treatment history was not reported . Previous pregnancy end date was 04 Oct 2018 outcome was live birth.
Adult dose of Hep. A was given to 9 year old. Age of patient at time of event: 9 years.
c/o fatigue x 1wk & devel a fever on 6/5/99;also devel jaundice to skin & eyes;saw MD 6/8/99 & 6/15/99;
Second dose (first was not problematic). Flu-like symptoms: muscle aches, chills, weakness.
felt like she had COVID all over again which last 48 hours; felt like she had COVID all over again which last 48 hours; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration on 30Jan2021 at a single dose for COVID-19 immunization.  Medical history included COVID-19 from an unknown date and unknown if ongoing.  The patient's concomitant medications were not reported. The patient received first dose of COVID-19 vaccine on 30Jan2021 and stated that after her first COVID-19 vaccine she felt like she had COVID all over again which last 48 hours. She is asking if she has to get the second COVID-19 vaccine after having the virus. The patient recovered from the event on unspecified date.   Information on the lot/batch number has been requested.
Approximately three days after receiving the Covid 19 vaccination  the patient and her husband (separate VAERS report submitted) started experiencing  the following symptoms: tiredness, loss of appetite, nausea and some vomiting. On the fifth day the patient and her husband experienced extreme diarrhea.  They went to the doctor when the diarrhea occurred. The doctor prescribed antibiotics.
Patient complained of itching at injection site 15 minutes after administration. Within 10 minutes (approximately 25 minutes post injection) patient complained of further itching to face and presented visible flushing of face.
Got shot at 2:30 pm and started developing itching, redness and swelling at injection site-swelling was at 8 cm diameter at 4:30 pm - was firm and warm to the touch. Started decreasing by 8:30 am after she was instructed to take our capsule of diphenhydramine. Today swelling is significantly decreased. No longer red or itching-probably local allergic reaction.
COVID-19 infection/unknown exposure/ 3 pfizer vaccination; COVID-19 infection/unknown exposure/ 3 pfizer vaccination; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 32-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (caused and prolonged hospitalization, medically significant), COVID-19 (caused and prolonged hospitalization, medically significant) all with onset 26Jul2022, outcome "recovered" (29Jul2022) and all described as "COVID-19 infection/unknown exposure/ 3 pfizer vaccination". The patient was hospitalized and prolonged hospitalization for drug ineffective, covid-19 (start date: 26Jul2022, discharge date: 29Jul2022, hospitalization duration: 4 day(s)). Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on temporal association and known drug profile, a contributory role of suspect drug cannot be excluded for the reported events, COVID-19 and DRUG INEFFECTIVE.
2/2/21 received COVID vaccine at hospital clinic. 2/6/21 headache began then 2/10/21 numbness on the left side of face including eye, eyebrow, nose, and mouth.  2/11/21 Primary doctor visit diagnosis Bell's palsy on left side meds given prednisone, Valacyclovir, increased metformin, and amlodipine.  Still having symptoms of numbness, no taste, eye lid doesn't close makes eye water and frequent headaches.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Course: Patient Paxlovid Treatment from 27Jun2023 to 01Jul2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300242788 Same patient, different drug, different event;
Swelling at inject site, itching at inject site & over other parts of body. Joint aches, nausea.
pt given H1N1 vaccine 20min later she felt itchy, arm turning red, felt tongue enlarging. pt given 25mg Benadryl 25mg im, pt improved sent home on prn Benadryl and prednisone burst pack
Chills, body aches, lethargy,  pain and  swelling at injection site
Nerve pain; Body pain; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (Nerve pain) and MYALGIA (Body pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m20a) for COVID-19 vaccination.     The patient's past medical history included Neuropathy, Fibromyalgia and Restless leg syndrome.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced NEURALGIA (Nerve pain) and MYALGIA (Body pain). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, NEURALGIA (Nerve pain) and MYALGIA (Body pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included blood pressure and Cholesterol medicines.     This case was linked to US-MODERNATX, INC.-MOD-2021-063949 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow-up received on 13 May 2021 and contains non-significant information. On 25-May-2021: Follow-up received on 25 May 2021 and contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-063949:Second Dose
on 12/30, I experienced a sudden onset of extreme dizziness. I proceeded to have one of the nurse techs I work with check my blood pressure in both arms. I was 198/103 and 190/100. A headache was starting, dizziness continued. They (NT) told me I didn't look good and my face was very red. I waited 15-20 minutes, sitting down and in a darken room,  the NT checked again and BP was 168//100. So I called Nursing supervisor, who left it up to me to go home or ED. I choose ED. IN ED they did EKG (-), Cat scan (-), nuero checks often that were fine, labwork  all fine. I was admitted because they wanted to follow up with an MRI in morning and continue nuero checks overnight. BP returned to normal when nighttime dose of Carvedilol was given along with and extra dose of HCTZ. Dizziness lessened but did not completely abate. Doctors recommended vestibular rehab. Pt doing PT 2x a week on going.
Information has been received from the mother concerning her daughter who a couple of weeks ago was vaccinated with the first dose of GARDASIL. On an unknown date, the patient experienced leg pain associated with joint pain for about two weeks. This was just reported to the doctor. The pain has resolved and the parent doesn't want the daughter to receive the second or third dose. Patient was not given other medications and not involved in heavy exercise. Additional information has been requested.
14 unspecified patients received improperly stored doses of ROTATEQ; This spontaneous report was received from a nurse referring 14 unspecified patients of unknown age and gender. Information about pertinent medical history, drug reactions/allergies and concomitant therapies was not provided.    On unspecified dates from 16-DEC-2019 to 03-JAN-2020, the patients received improperly stored doses (product storage error) of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # R033255 and expiration date 26-JUN-2020; strength, dose, frequency and route were not reported) for prophylaxis. The vaccine underwent highest temperature above 47 degrees Fahrenheit (48.7 Fahrenheit) for a duration of 1 hour and 24 minutes. There was no previous temperature excursion and the call was because of data logger.   This is a non-valid case due to lack of patient identifiers.  As of 25-JUN-2020, a telephone attempt trying to obtain additional information have been unsuccessful.
Loud ringing in both ears started around 5:00 pm the day of the vaccine.  Gradually got better over course of two weeks, but still experiencing ringing. Tingling/ numbness/neuropathy in right arm, right hand, right leg, right foot started day after the vaccine. Left arm, hand neuropathy, as well.
Backache; Fever; Muscle pain; Chills; Fatigued; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), PYREXIA (Fever), MYALGIA (Muscle pain), CHILLS (Chills) and FATIGUE (Fatigued) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced BACK PAIN (Backache), PYREXIA (Fever), MYALGIA (Muscle pain), CHILLS (Chills) and FATIGUE (Fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (Backache), PYREXIA (Fever), MYALGIA (Muscle pain), CHILLS (Chills) and FATIGUE (Fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
1st dose on 29 Sep 2021 and 2nd dose on 20 Oct 2021; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 29 Sep 2021 and 2nd dose on 20 Oct 2021) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039D21A and 026D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 20-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 20-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 29 Sep 2021 and 2nd dose on 20 Oct 2021). On 20-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 29 Sep 2021 and 2nd dose on 20 Oct 2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.